Kaye Edmonton Clinic

Edmonton, Alberta T6G1Z1

0 studies enrolling now · 8 studies all time

What they study most

ECG, HIV-1-infection, Hemophilia A, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lower Respiratory Tract Illness, Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Myelodysplastic Syndrome, Oral Lichen Planus, Pharmacokinetics, Safety

Studies at this site

• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors — Completed
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A — Completed
• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML — Completed
• Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed — Completed
• Intra-oral Treatment of OLP With Rivelin®-CLO Patches — Completed